Product Name
    Supplier
    Clonality
    Application
    Reactivity
    Price
    - 
          Recombinant Macrovipera lebetina obtusa Disintegrin obtustatin (CSB-YP306081VDJ)CUSABIO $436.00 - $826.00
- 
          
- 
          Recombinant Human Cation-independent mannose-6-phosphate receptor(IGF2R),partial (CSB-YP011093HU)CUSABIO $276.00 - $2,310.00
- 
          Recombinant Bovine Cation-independent mannose-6-phosphate receptor(IGF2R),partial (CSB-YP011093BOc7)CUSABIO $436.00 - $2,959.00
- 
          Recombinant Bovine Cation-independent mannose-6-phosphate receptor(IGF2R),partial (CSB-YP011093BO)CUSABIO $602.00 - $3,125.00
- 
          Recombinant Human Heterogeneous nuclear ribonucleoproteins A2/B1(HNRNPA2B1) (CSB-YP010602HUc7)CUSABIO $250.00 - $470.00
- 
          
- 
          
- 
          Recombinant Human E3 ubiquitin-protein ligase AMFR(AMFR),partial (CSB-MP892337HU1)CUSABIO $256.00 - $3,168.00
- 
          
- 
          Recombinant Dendroaspis angusticeps Dendrotoxin B(N/A),partial (CSB-MP882468DBG)CUSABIO $660.00 - $7,762.00
- 
          Recombinant Mouse Collagen triple helix repeat-containing protein 1(Cthrc1) (CSB-MP875181MO)CUSABIO $660.00 - $7,762.00
- 
          
- 
          Recombinant Human Complement component C1q receptor(CD93),partial (Active) (CSB-MP865099HU)CUSABIO $114.00 - $284.00
- 
          Recombinant Human MAPK-interacting and spindle-stabilizing protein-like(MAPK1IP1L) (CSB-MP850865HU)CUSABIO $660.00 - $7,762.00
- 
          
- 
          Recombinant Canis lupus familiaris Trefoil factor 3(TFF3) (CSB-MP801125DO)CUSABIO $660.00 - $1,848.00
- 
          
- 
          
- 
          
- 
          
- 
          Recombinant Canis lupus familiaris Angiopoietin-1(ANGPT1) (CSB-MP713940DO)CUSABIO $660.00 - $7,762.00
- 
          
- 
          Recombinant Macaca fascicularis CD44 antigen(CD44),partial (Active) (CSB-MP4290MOV)CUSABIO $190.00 - $370.00
- 
          Recombinant Macaca fascicularis CD93 molecule(CD93),partial (Active) (CSB-MP4279MOV)CUSABIO $114.00 - $284.00
- 
          
- 
          
- 
          
- 
          
- 
          
 
        